Trial Profile
A Proof of Concept (PoC) Study to Evaluate the Safety, Tolerability, and Efficacy of 12 Week Administration of BFH772 Ointment in Rosacea Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Aug 2020
Price :
$35
*
At a glance
- Drugs Betamethasone/calcipotriol (Primary) ; Metronidazole; Metronidazole/miconazole
- Indications Erythema; Rosacea
- Focus Therapeutic Use
- Sponsors Novartis
- 07 May 2014 New trial record